Matrixx Initiatives Inc recalls Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and d
Recalled February 13, 2013 · FDA recall D-155-2013 · Matrixx Initiatives
Hazard
Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia. · FDA Class I
Units
46,752 bottles
Sold at
Nationwide.
Description
Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.
Product
Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.
Manufacturer(s)
Matrixx Initiatives Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →